By Professor Caroline Ford

Conference Abstracts

Macdonald ER; Rose G; Simar D; McCarthy AL; Ford C; Warton K; Hayes S; Clifford BK, 2026, 'Evaluating the utility of circulating cell-free DNA in the context of endometrial cancer: a systematic scoping review', in International Journal of Gynecological Cancer, Vol. 36, http://dx.doi.org/10.1016/j.ijgc.2026.104767

Madani D; Satgunaseelan L; El-Hayek J; Shivalingam B; Ford C, 2024, 'ROR1 MRNA EXPRESSION IN GLIOMA - A NOVEL PROGNOSTIC BIOMARKER', in Neuro-Oncology, Oxford University Press (OUP), Vol. 26, pp. vii4 - vii5, http://dx.doi.org/10.1093/neuonc/noae158.016

Werner B; Powell E; Duggan J; Cortesi M; Lee YC; Arora V; Athavale R; Dean M; Warton K; Ford C, 2024, 'Use of cell-free DNA from ascites to identify variants and tumour evolution in a cohort of patients with advanced ovarian cancer', in Journal of Clinical Oncology, American Society of Clinical Oncology, Vol. 42, presented at 2024 ASCO Annual Meeting, 29 May 2024 - 29 May 2024, http://dx.doi.org/10.1200/JCO.2024.42.16_suppl.5547

Phan Z; Ford CE; Caldon E, 2024, 'Abstract A115: DNA repair biomarkers to guide usage of combined PARP inhibitors and chemotherapy: A meta-analysis and systematic review', in Cancer Research, American Association for Cancer Research (AACR), Vol. 84, pp. a115 - a115, http://dx.doi.org/10.1158/1538-7445.ovarian23-a115

Liu D; Powell E; Wan KM; Athavale R; Loo C; Ford CE, 2024, 'Abstract B014: Patient-derived organoid models for drug screening in molecular subtypes of endometrial cancer', in Clinical Cancer Research, American Association for Cancer Research (AACR), Vol. 30, pp. b014 - b014, http://dx.doi.org/10.1158/1557-3265.endo24-b014

Liu D; Enriquez L; Daniels B; O'Mara T; Tang K; Ford C, 2020, 'ROR2 is epigenetically regulated in endometrial cancer', in CLINICAL CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, ELECTR NETWORK, Vol. 27, presented at AACR Special Conference on Endometrial Cancer - New Biology Driving Research and Treatment, ELECTR NETWORK, 09 November 2020 - 10 November 2020, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000617951200068&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Liu D; Gunther K; Daniels B; O'Mara T; Tang K; Ford C, 2020, 'Abstract 2942: ROR1: A novel target in endometrial cancer', in Cancer Research, American Association for Cancer Research (AACR), Vol. 80, pp. 2942 - 2942, http://dx.doi.org/10.1158/1538-7445.am2020-2942

Yuwono NL; Warton K; Henry C; Ford C, 2020, 'Abstract 731: Deciphering the origin of circulating cell-free DNA and its alterations during menstruation', in Cancer Research, American Association for Cancer Research (AACR), Vol. 80, pp. 731 - 731, http://dx.doi.org/10.1158/1538-7445.am2020-731

Liu D; John M; Henry CE; Christie EL; Bowtell DDL; Tang K; Heinzelmann-Schwarz V; Kennedy C; Boros J; DeFazio A; Ford CE, 2019, 'ROR1 is associated with ovarian cancer progression and chemoresistance.', in CLINICAL CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, GA, Atlanta, Vol. 26, pp. 59 - 60, presented at AACR Special Conference on Advances in Ovarian Cancer Research, GA, Atlanta, 13 September 2019 - 16 September 2019, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000546013300077&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Back to profile page